Trial
NCT01694264
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Seoul National University Hospital
Collaborators
Konkuk University Medical Center; Kyungpook National University Hospital; Kyunghee University Medical Center; Kyung Hee University Hospital at Gangdong; Gachon University Gil Medical Center; Daegu Catholic University Medical Center; Eulji University Hospital; SMG-SNU Boramae Medical Center; The Catholic University of Korea; Severance Hospital; Ajou University School of Medicine; Ewha Womans University Mokdong Hospital; Inha University Hospital; Chonnam National University Hospital; Chonbuk National University Hospital; Chungnam National University Hospital; Hallym University Medical Center; Hanyang University; Dong-A University; Korea University Guro Hospital
Condition
Chronic Hepatitis B
Intervention
Entecavir
Why stopped
Delayed recruitment, unable to meet calculated sample size
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-06